News

The collaboration will work for the improvement, diagnosis and awareness of HCV infection in developed and emerging markets. The researchers of Merck and Roche are expected to investigate

In 2010, both the companies have signed a multi-year target validation agreement under which Tekmira offers Bristol-Myers Squibb with LNP formulations designed to validate the function of certain

Millennium Healthcare Solutions subsidiaries include Millennium Coding & Billing Specialists, Millennium ProComm and Millennium Medical Devices. Millennium Coding & Billing Specialists has aligned itself with its strategic partners

The new guidelines, updated for the first time in more than 25 years, discuss the importance of new technologies, including brain imaging and biomarker analysis, in research and

The VerifyNow System helps physicians find an individual’s platelet response to multiple antiplatelet agents. It provides information to help physicians make informed treatment decisions, as it addresses every

With this acquisition, Shire plans to expand Advanced BioHealing’s manufacturing facility and research laboratories. Shire will add Dermagraft in its product portfolio, which is indicated for the use

The Swissmedic approval was based on the results from a Phase II study (Study 211) of Halaven and the Phase III EMBRACE study (Eisai Metastatic Breast Cancer Study

China BCT’s net income was $6.25m, or $0.16 per diluted share, compared to net income of $4.24m, or $0.00 per diluted share, for the comparable period last year.

Under the terms of the companies’ 2009 joint venture arrangement, Maxygen transferred all of its protein pharmaceutical programs and related assets and research and development personnel to Perseid